ClinicalTrials.govpublic full text
Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia
patients with b cell all, relapsed or refractory, with no available curative treatment options, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889952
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.